Red ginseng acidic polysaccharide (RGAP) in combination with IFN-γ results in enhanced macrophage function through activation of the NF-κB pathway

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 7, 2008, Pages 1817-1825

  Choi, Hye Sook ^a   Kim, Kyung Ho ^a   Sohn, Eunwha ^b   Park, Jong Dae ^c   Kim, Byung Oh ^d   Moon, Eun Yi ^e   Rhee, Dong Kwon ^a   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Kangwon National University   (South Korea)

^c KT and G Central Research Institute   (South Korea)

^d Kyungpook National University   (South Korea)

^e Sejong University   (South Korea)

Author keywords

Cytokines; Macrophage; NF B; NO; Red ginseng acidic polysaccharide

Indexed keywords

ACTIVATION ANALYSIS; ELECTRIC LOAD MANAGEMENT; ELECTROPHORETIC MOBILITY; GLYCOPROTEINS; NITRIC OXIDE; NONMETALS; OXYGEN; POLYSACCHARIDES; TRANSCRIPTION FACTORS; TUMORS;

CLINICAL STUDIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY ANALYSIS; INTERLEUKIN (IL) 1; MELANOMA B16; NITRIC OXIDE (CO); NUCLEAR FACTOR (NF); REACTIVE OXYGEN SPECIES (ROS); RED GINSENG; SYNERGISTIC EFFECTS (SE); TUMOR CELLS; TUMOR NECROSIS FACTOR (NCF);

MACROPHAGES;

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; POLYSACCHARIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; GINSENG; IMMUNOLOGY; MACROPHAGE; MELANOMA; METABOLISM; MOUSE; PHAGOCYTOSIS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; INTERFERON TYPE II; MACROPHAGES; MELANOMA; MICE; NF-KAPPA B; NITRIC OXIDE; PANAX; PHAGOCYTOSIS; POLYSACCHARIDES;

MURINAE; PANAX GINSENG;

EID: 47949092327     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80085     Document Type: Article

References (37)

1. Lee, K. D., and Huemer, R. P., Antitumoral activity of Panax ginseng extracts. Jpn. J. Pharmacol., 21, 299-301 (1971).
2. Yun, T. K., Yun, Y. S., and Han, I. W., Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect. Prev., 6, 515-525 (1983).
3. Yun, T. K., and Choi, S. Y., A case-control study of ginseng intake and cancer. Int. J. Epidemiol., 19, 871-875 (1990).
4. Park, K. M., Kim, Y. S., Jeong, T. C., Joe, C. O., Shin, H. J., Lee, Y. H., Nam, K. Y., and Park, J. D., Nitric oxide is involved in the immunomodulating activities of acidic polysaccharide from Panax ginseng. Planta Med., 67, 122-126 (2001).
5. Shin, H. J., Kim, Y. S., Kwak, Y. S., Song, Y. B., Kim, Y. S., and Park, J. D., Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP). Planta Med., 70, 1033-1038 (2004).
6. Kim, Y. S., Park, K. M., Shin, H. J., Nam, K. Y., and Park, J. D., Anticancer activities of red ginseng acidic polysaccharide by activation of macrophages and natural killer cells. Yakhak Hoeji, 46, 113-119 (2002).
7. Hahn, H., and Kaufmann, S. H., The role of cellmediated immunity in bacterial infections. Rev. Infect. Dis., 3, 1221-1250 (1981).
8. Verstovsek, S., Maccubbin, D. L., Ehrke, M. J., and Mihich, E., Tumoricidal activation of murine resident peritoneal macrophages by interleukin-2 and tumor necrosis factor. Cancer Res., 52, 3880-3885 (1992).
9. Klimp, A. H., de Vries, E. G., Scherphof, G. L., and Daemen, T., A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol., 44, 143-161 (2002).
10. Dullens, H. F. J., De Weger, R. A., Van Der Maas, M., Den Besten, P. J., Vandebriel, R. J., and Den Otter, W., Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection. Cancer Immunol. Immunother., 30, 28-33 (1989).
11. Gautam, S., and Deodhar, S., Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J. Biol. Response Mod., 8, 560-569 (1989).
12. Paulnock, D. M., and Lambert, L. E., Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. J. Immunol., 144, 765-773 (1988).
13. Um, S. H., Son, E. W., Kim, B. O., Moon, E. Y., Rhee, D. K., and Pyo, S., Activation of murine peritoneal macrophages by Streptococcus pneumoniae type II capsular polysaccharide: involvement of CD14-dependent pathway. Scand. J. Immunol., 52, 39-45 (2000).
14. Bae, S. Y., Yim, J. H., Lee, H. K., and Pyo, S., Activation of murine peritoneal macrophages by sulfated exopolysaccharide from marine microalga Gyrodinium impudicum (strain KG03): involvement of the NF-kappaB and JNK pathway. Int. Immunopharmacol., 6, 473-484 (2006).
15. Stuehr, D. J., and Marletta, M. A., Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res., 47, 5590-5594 (1987).
16. Choriki, M., Freudenberg, M., Calanos, C., Poindron, P., and Bartholeyns, J., Antitumoral effects of lipopolisacchride, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res., 9, 1185-1190 (1989).
17. Keller, R., Keist, R., and Frei, K., Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur. J. Immunol., 20, 695-698 (1990).
18. Hori, K., Ehrke, M. J., and Mihich, E., Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and interferon gamma. Cancer Res., 47, 5068-5073 (1987).
19. Jiang, H., Stewart, C. A., Fast, D. J., and Leu, R. W., Tumor target derived soluble factors synergize with IFN-γ and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Immunol., 149, 2137-2146 (1992).
20. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C., Structure and function of lipopolysaccharide binding protein. Science, 249, 1431-1433 (1990).
21. Dong, Z., O'Brian, C. A., and Fidler, I. J., Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosin kinase activity. J. Leukoc. Biol., 53, 53-60 (1993).
22. Um, S. H., Rhee, D. K., and Pyo, S., Involvement of protein kinase C and tyrosin kinase in tumoricidal activation of macrophage induced by Streptoccus pneumoniae type II capsular polysaccharide. Int. Immunopharmacol., 2, 129-137 (2002).
23. Jaramillo, M., Naccache, P. H., and Olivier, M., Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. J. Immunol., 172, 5734-5742 (2004).
24. Kuprash, D. V., Udalova, I. A., Turetskaya, R. L., Rice, N. R., and Nedospasov, S. A., Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene, 11, 97-106 (1995).
25. Sweet, M. J., and Hume, D. A., Endotoxin signal transduction in macrophages. J. Leukoc. Biol., 60, 8-26 (1996).
26. Chaplin, M. F., Monosaccharides. In "Carbohydrate Analysis," eds. Chaplin, M. F., and Kennedy, N. K., IRL Press, Oxford, pp. 1-40 (1994).
27. Okimura, T., Ogawa, M., and Yamauchi, T., Stress and immune responses. III. Effect of resistant stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity and phagocytosis in mice. Jpn. J. Pharmacol., 41, 229-235 (1986).
28. Ding, A. H., Nathan, C. F., and Stue, D. J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol., 141, 2407-2412 (1988).
29. Cho, S. J., Kang, N. S., Park, S. Y., Kim, B. O., Rhee, D. K., and Pyo, S., Induction of apoptosis and expression of apoptosis related genes in human epithelial carcinoma cells by Helicobacter pylori VacA toxin. Toxicon, 42, 601-611 (2003).
30. Barnes, P. J., and Karin, M., Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066-1071 (1997).
31. Ghosh, S., Bhattacharyya, S., Sirkar, M., Sa, G. S., Das, T., Majumdar, D., Roy, S., and Majumdar, S., Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect. Immun., 70, 6828-6838 (2002).
32. Adams, D. O., and Hamilton, T. A., The cell biology of macrophage activation. Ann. Rev. Immunol., 2, 283-318 (1984).
33. Kreutz, M., Fritsche, J., and Andressen, R., Macrophages in tumor biology. In "The Macrophages," eds. Burke, B., and Lewis, C., IRL Press, Oxford, pp. 457-474 (2002).
34. Xagorari, A., Papapetropoulos, A., Mauromatis, A., Economou, M., Fotsis, T., and Roussos, C., Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther., 296, 181-187 (2001).
35. Romics, L., Kodys, K., Dolganiuc, A., Graham, L., Velayudham, A., Mandrekar, P., and Szabo, G., Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Hepatology, 40, 376-385 (2004).
36. Park, Y. M., Won, J. H., Yun, K. J., Ryu, J. H., Han, Y. N., Choi, S. K., and Lee, K. T., Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappaB in RAW 264.7 cells. Biol. Pharm. Bull., 29, 985-990 (2006).
37. Aktan, F., iNOS-mediated nitric oxide production and its regulation. Life Sci., 75, 639-653 (2004).